- Home
- BEAT vs GCV Comparison
BEAT vs GCV Comparison
Compare BEAT & GCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- GCV
- Stock Information
- Founded
- BEAT 2015
- GCV 1988
- Country
- BEAT United States
- GCV United States
- Employees
- BEAT N/A
- GCV N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- GCV Finance/Investors Services
- Sector
- BEAT Technology
- GCV Finance
- Exchange
- BEAT Nasdaq
- GCV Nasdaq
- Market Cap
- BEAT 65.4M
- GCV 75.6M
- IPO Year
- BEAT 2021
- GCV N/A
- Fundamental
- Price
- BEAT $2.00
- GCV $3.73
- Analyst Decision
- BEAT Buy
- GCV
- Analyst Count
- BEAT 1
- GCV 0
- Target Price
- BEAT $8.00
- GCV N/A
- AVG Volume (30 Days)
- BEAT 57.4K
- GCV 57.9K
- Earning Date
- BEAT 03-13-2025
- GCV 01-01-0001
- Dividend Yield
- BEAT N/A
- GCV 13.04%
- EPS Growth
- BEAT N/A
- GCV N/A
- EPS
- BEAT N/A
- GCV N/A
- Revenue
- BEAT N/A
- GCV N/A
- Revenue This Year
- BEAT N/A
- GCV N/A
- Revenue Next Year
- BEAT N/A
- GCV N/A
- P/E Ratio
- BEAT N/A
- GCV N/A
- Revenue Growth
- BEAT N/A
- GCV N/A
- 52 Week Low
- BEAT $1.70
- GCV $3.15
- 52 Week High
- BEAT $3.48
- GCV $4.58
- Technical
- Relative Strength Index (RSI)
- BEAT 46.64
- GCV 39.29
- Support Level
- BEAT $1.85
- GCV $3.64
- Resistance Level
- BEAT $2.03
- GCV $3.86
- Average True Range (ATR)
- BEAT 0.11
- GCV 0.09
- MACD
- BEAT 0.00
- GCV -0.00
- Stochastic Oscillator
- BEAT 51.35
- GCV 34.62
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.